Coagulation Testing Market is Expected to exhibit a solid 9% CAGR in the 2017-2025

1
Product - Instruments, Consumables Test Type
PT, APTT, TT, and ACT End User - Hospitals and
Clinics, Diagnostic Laboratories, and Home Care
SettingsForecast From 2017 - 2025
Coagulation Testing Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Market Analysis, by Component
Chapter 6 Market Analysis, by Data Type
Chapter 7 Market Analysis, by Application
Chapter 8 Market Analysis, by Region
Chapter 9 Competition Landscape
Chapter 10 Company Profiles
Chapter 11 Key Takeaways
3
Coagulation Testing Market Snapshot

• Blood testing measuring the bloods ability to
  clot and the time taken for the same is known as
  coagulation testing.
• Global coagulation testing market is witnessing
  significant growth due to growing prevalence of
  blood clotting disorders in many regions and the
  rise in cardiovascular disorders, which can also
  require regular coagulation testing.
• global coagulation testing market is segmented on
  the basis of product type into instruments and
  consumables.

4
Reports Highlights

• Global market for coagulation testing was worth
  US1,730 million in 2016, and is expected to
  exhibit a solid 9 CAGR in the 2017-2025 forecast
  period to end up at a valuation of US3,715.8
  million.
• Major players -
• Alere Inc., F. Hoffmann-La Roche Ltd., Abbott
  Laboratories, Siemens Healthineers, SYSMEX
  CORPORATION, Universal Biosensors, Inc.,
  HemoSonics, LLC, and Helena Laboratories

Request Sample
5
(No Transcript)